Expression of multiple endocrine neoplasia 2B RET in neuroblastoma cells alters cell adhesion in Vitro, enhances metastatic behavior in Vivo, and activates Jun kinase

Cancer Research

Volumn 57, Issue 23, 1997, Pages 5399-5405

  Marshall, Glenn M ^a   Peaston, Anne E ^a   Hocker, Jayne E ^a   Smith, Stewart A ^a   Hansford, Loen M ^a   Tobias, Vivienne ^b   Norris, Murray D ^a   Haber, Michelle ^a   Smith, Darrin P ^c   Lorenzo, Maria J ^c   Ponder, Bruce A J ^c   Hancock, John F ^d  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL ADHESION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE DISRUPTION; GENE FREQUENCY; GENETIC TRANSFECTION; HIRSCHSPRUNG DISEASE; HUMAN; HUMAN CELL; LUNG METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; NEURAL CREST; NEUROBLASTOMA CELL; POINT MUTATION; PRIORITY JOURNAL; PROTO ONCOGENE;

AMINO ACID SUBSTITUTION; ANIMALS; CELL DIVISION; COS CELLS; DROSOPHILA PROTEINS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; NEOPLASM METASTASIS; NEURAL CREST; NEUROBLASTOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; PROTO-ONCOGENES; RECEPTOR PROTEIN-TYROSINE KINASES; RECOMBINANT PROTEINS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 15144348923     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Pachnis, V., Mankoo, B., and Costantini, F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development (Camb.), 119: 1005-1017, 1993.
2. Tahira, T., Ishizaka, Y., Sugimura, T., and Nagao, M. Expression of proto-ret mRNA in embryonic and adult rat tissues. Biochem. Biophys. Res. Commun., 153: 1290-1295, 1988.
3. Jing S., Wen, D., Yu, Y., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., Louis, J. C., Hu, S., Altrock, B. W., and Fox, G. M. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell, 85: 1113-1124, 1996.
4. Durbec, P., Marcos-Gutierrez, C. V., Kilkenny, C., Grigoriou, M., Wartiowaara, K., Suvanto, P., Smith, D. P., Ponder, B. A. J., Costantini, F., Saarma, M., Sariola, H., and Pachnis, V. GDNF signalling through the Ret receptor tyrosine kinase. Nature (Lond.), 381: 789-793, 1996.
5. Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A. S., Seiber, B. E., Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V., Arumäe, U., Sariola, H., Saarma, M., and Ibáñez, C. F. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature (Lond.), 381: 785-789, 1996.
6. Treanor, J. J. S., Goodman, L., de Sauvage, F., Stone, D. M., Poulsen, K. T., Beck, C. D., Gray, C., Armanini, M. P., Pollock, R. A., Hefti, F., Phillips, H. S., Goddard, A., Moore, M. W., Buj-Bello, A., Davies, A. M., Asai, N., Takahashi, M., Vandlen, R., Henderson, C. E., and Rosenthal, A. Characterization of a multicomponent receptor for GDNF. Nature (Lond.), 382: 80-83, 1996.
7. Pichel, J. G., Shen, L., Sheng, H. Z., Granholm, A. C., Drago, J., Grinberg, A., Lee, E. J., Huang, S. P., Saarma, M., Hoffer, B. J., Sariola, H., and Westphal, H. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature (Lond.), 382: 73-76, 1996.
8. Moore, M. W., Klein, R. D., Fariñas, I., Sauer, H., Armanini, M., Philips, H., Reichardt, L. F., Ryan, A. M., Carver-Moore, K., and Rosenthal, A. Renal and neuronal abnormalities in mice lacking GDNF. Nature (Lond.), 382: 76-79, 1996.
9. Sánchez, M. P., Silos-Santiago, I., Frisén, J., He, B., Lira, S. A., and Barbacid, M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature (Lond.), 382: 70-73, 1996.
10. Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F., and Pachnis, V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature (Lond.), 367: 380-383, 1994.
11. Edery, P., Lyonnet, S., Mulligan, L. M., Pelet, A., Dow, E., Abel, L., Holder, S., Nihoul-Fékété, C., Ponder, B. A. J., and Munnich, A. Mutations of the RET protooncogene in Hirschsprung's disease. Nature (Lond.), 367: 378-380, 1994.
12. Romeo, G., Ronchetto, P., Luo, Y., Barone, V., Seri, M., Ceccherini, I., Pasini, B., Bocciardi, R., Lerone, M., Kääriäinen, H., and Martucciello, G. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature (Lond.), 367: 377-378, 1994.
13. Carlson, K. M., Dou, S., Chi, D., Scavarda, N., Toshima, K., Jackson, C. E., Wells, S. A., Goodfellow, P. J., and Donis-Keller, H. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc. Natl. Acad. Sci. USA, 91: 1579-1583, 1994.
14. Donis-Keller, H., Dou, S., Chi, D., Carlson, K. M., Toshima, K., Lairmore, T. C., Howe, J. R., Moley, J. F., Goodfellow, P. J., and Wells, S. A. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum. Mol. Genet., 2: 851-856, 1993.
15. Eng, C., Smith, D. P., Mulligan, L. M., Nagai, M. A., Healey, C. S., Ponder, M. A., Gardner, E., Scheumann, G. F. W., Jackson, C. E., Tunnacliffe, A., and Ponder, B. A. J. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum. Mol. Genet., 3: 237-241, 1994.
16. Hofstra, R. M. W., Landsvater, R. M., Ceccherini, I., Stulp, R. P., Stelwagen, T., Luo, Y., Pasini, B., Höppener, J. W. M., Van Amstel, H. K. P., Lips, C. J. M., and Buys, C. H. C. M. A mutation in the RET protooncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature (Lond.), 367: 375-376, 1994.
17. Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., Ponder, M. A., Telenius, H., Tunnacliffe, A., and Ponder, B. A. J. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature (Lond.), 363: 458-460, 1993.
18. Bolino, A., Schuffenecker, I., Luo, Y., Seri, M., Silengo, M., Tocco, T., Chabrier, G., Houdent, C., Murat, A., Schlumberger, M., Tourniaire, J., Lenoir, G. M., and Romeo, G. RET mutations in exons 13 and 14 of FMTC patients. Oncogene, 10: 2415-2419, 1995.
19. Eng, C., Smith, D. P., Mulligan, L. M., Healey, C. S., Zvelebil, M. J., Stonehouse, R. J., Ponder, M. A., Jackson, C. E., Waterfield, M. D., and Ponder, B. A. J. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene, 10: 509-513, 1995.
20. Songyang, Z., Carraway, K. L. I., Eck, M. J., Harrison, S. C., Feldman, R. A., Mohammadi, M., Schlessinger, J., Hubbard, S. R., Smith, D. P., Eng, C., Lorenzo, M. J., Ponder, B. A. J., Mayer, B. J., and Cantley, L. C. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature (Lond.), 373: 536-539, 1995.
21. Ikeda, I., Ishizaka, Y., Tahira, R., Suzuki, R., Onda, M., Sugimura, R., and Nagao, M. Specific expression of the ret proto-oncogene in human neuroblastoma cell lines. Oncogene, 5: 1291-1296, 1990.
22. Nagao, M., Ishizaka, Y., Nakagawara, A., Kohno, K., Kuwano, M., Tahira, T., Itoh, F., Ikeda, I., and Sugimura, T. Expression of ret proto-oncogene in human neuroblastoma. Jpn. J. Cancer Res., 81: 309-312, 1990.
23. Santoro, M., Rosati, R., Grieco, M., Berlingieri, M. T., D'Amato, G. L., de Franciscis, V., and Fusco, A. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene, 5: 1595-1598, 1990.
24. Takahashi, M., Buma, Y., and Taniguchi, M. Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells. Oncogene, 6: 297-301, 1991.
25. Iwamoto, T., Taniguchi, M., Wajjwalku, W., Nakashima, I., and Takahashi, M. Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene. Br. J. Cancer, 67: 504-507, 1993.
26. Borrello, M. G., Bongarzone, I., Pierotti, M. A., Luksch, R., Gasparini, M., Collini, P., Pilotti, S., Rizzetti, M. G., Mondellini, P., De Bernardi, B., DiMartino, D., Garaventa, A., Brisigotti, M., and Tonini, G. P. trk and ret proto-oncogene expression in human neuroblastoma specimens: high frequency of trk expression in non-advanced stages. Int. J. Cancer, 54: 540-545, 1993.
27. Itoh, F., Ishizaka, Y., Tahira, T., Yamamoto, M., Miya, A., Imai, K., Yachi, A., Takai, S., Sugimura, T., and Nagao, M. Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients. Oncogene, 7: 1201-1206, 1992.
28. Tahira, T., Ishizaka, Y., Itoh, F., Nakayasu, M., Sugimura, T., and Nagao, M. Expression of the ret proto-oncogene in human neuroblastoma cell lines and its increase during neuronal differentiation induced by retinoic acid. Oncogene, 6: 2333-2338, 1991.
29. Asai, N., Iwashita, T., Matsuyama, M., and Takahashi, M. Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol. Cell. Biol., 15: 1613-1619, 1995.
30. Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., and Di Fiore, P. P. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science (Washington DC), 267: 381-383, 1995.
31. Cano, E., and Mahadevan, L. C. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci., 20: 117-122, 1995.
32. Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80: 179-185, 1995.
33. Vojtek, A. B., and Cooper, J. A. Rho family members: activators of MAP kinase cascades. Cell, 82: 527-529, 1995.
34. Han, J., Lee, J-D., Bibbs, L., and Ulevitch, R. J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science (Washington DC), 265: 808-811, 1994.
35. Borrello, M. G., Smith, D. P., Pasini, B., Bongarzone, I., Grieco, A., Lorenzo, M. J., Arighi, E., Miranda, C., Eng, C., Alberti, L., Bocciardi, R., Mondellini, P., Scopsi, L., Romeo, G., Ponder, B. A. J., and Pierotti, M. A. RET activation by germline MEN2A and MEN2B mutations. Oncogene, 11: 2419-2427, 1995.
36. Groger, R. K., Morrow, D. M., and Tykocinski, M. L. Directional antisense and sense cDNA cloning using Epstein-Barr virus episomal expression vectors. Gene (Amst.), 81: 285-294, 1989.
37. Marshall, G. M., Cheung, B., Stacey, K. P., Camacho, M. L., Simpson, A. M., Kwan, E., Smith, S. A., Haber, M., and Norris, M. D. Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells. Oncogene, 11: 485-491, 1995.
38. van Weering, D. H. J., Medema, J. P., van Puijenbroek, A., Burgering, B. M. T., Baas, P. D., and Bos, J. Ret receptor tyrosine kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells. Oncogene, 11: 2207-2213, 1995.
39. Fridell, Y-W. C., Jin, Y., Quilliam, L. A., Burchert, A., McCloskey, P., Spizz, G., Varnum, B., Der, C., and Liu, E. T. Differential activation of the Ras/extracellular signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase. Mol. Cell. Biol., 16: 135-145, 1996.
40. Coso, O. A., Chiariello, M., Yu, J. C., Teramoto, H., Crespo, P., Xu, N., Miki, T., and Gutkind, J. S. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell, 81: 1137-1146, 1995.
41. Minden, A., Lin, A., Claret, F. X., Abo, A., and Karin, M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell, 81: 1147-1157, 1995.
42. Ridley, A. J., and Hall, A. Signal transduction pathways regulating Rho-mediated stress fibre formation: requirement for a tyrosine kinase. EMBO J., 13: 2600-2610, 1994.
43. Albelda, S. M. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest., 68: 4-17, 1993.
44. Combaret, V., Gross, N., Lasset, C., Frappaz, D., Peruisseau, G., Philip, T., Beck, D., and Favrot, M. C. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 paediatric neuroblastomas. J. Clin. Oncol., 14: 25-34, 1996.
45. Huttenlocher, A., Sandborg, R. R., and Horwitz, A. F. Adhesion in cell migration. Curr. Opin. Cell Biol., 7: 697-706, 1995.
46. Harden N., Lee, J., Loh, H-Y., Ong, Y-M., Tan, I., Leung, T., Manser, E., and Lim, L. A Drosophila homologue of the Rac- and Cdc42-activated serine/threonine PAK is a potential focal adhesion and focal complex protein that colocalizes with dynamic actin structures. Mol. Cell. Biol., 16: 1896-1908, 1996.
47. D'Alessio, A., De Vita, G., Cali, G., Nitsch, L., Fusco, A., Vecchio, G., Santelli, G., Santoro, M., and de Franciscis, V. Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells. Cell Growth & Differ., 6: 1387-1394, 1995.
48. Hofstra, R. M. W., Cheng, N. C., Hansen, C., Stulp, R. P., Stelwagen, T., Clausen, N., Tommerup, N., Caron, H., Westerveld, A., Versteeg, R., and Buys, C. H. C. M. No mutations found by Ret mutation scanning in sporadic and hereditary neuroblastoma. Hum. Genet., 97: 362-364, 1996.